Zac Arbitman

December 12, 2023 | New Jersey Law Journal

Legal liability for the manufacture and sale of dangerous products can arise in different ways. Consumers harmed by such products often suffer significant property loss and/or grievous personal injuries and assert claims under the New Jersey Products Liability Act. Plaintiffs in Products Liability Act cases can be, but sometimes are not, purchasers of the products that caused them harm.

By Zac Arbitman and Samuel Mukiibi

7 minute read

October 21, 2021 | The Legal Intelligencer

While Leadbitter certainly refined some aspects of the watershed opinion it issued in Reginelli v. Boggs, credentialing information is still very much in play for plaintiffs in medical malpractice actions.

By Zac Arbitman

4 minute read

January 07, 2020 | The Legal Intelligencer

This four-part series combines perspectives from whistleblower and defense counsel to provide measured insight into each of the four main whistleblower regimes. In this third part, we discuss the CFTC whistleblower program.

By Zac Arbitman and Benjamin H. McCoy

7 minute read

September 16, 2019 | The Legal Intelligencer

Medical malpractice plaintiffs often find themselves suing several parties—one or more hospitals, multiple physicians and other health care providers—for the negligent care they received.

By Zac Arbitman

6 minute read

July 30, 2019 | The Legal Intelligencer

The SEC and CFTC whistleblower programs were created only in 2010 through the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act).

By Zac Arbitman and Benjamin H. McCoy

7 minute read

May 01, 2019 | The Legal Intelligencer

This article is the first in a series of four primers on the key legal regimes incentivizing and protecting whistleblowers who report fraud: the False Claims Act (FCA) and the Securities Exchange Commission (SEC), Commodity Futures Trading Commission (CFTC) and Internal Revenue Service (IRS) whistleblower programs

By Zac Arbitman and Benjamin H. McCoy

7 minute read

August 28, 2018 | The Legal Intelligencer

There is little dispute that the False Claims Act (FCA) is among the most potent weapons for fighting fraud and government waste. In just this past fiscal year alone, the DOJ utilized the FCA to recover more than $3.7 billion across a diverse array of industries such as health care, housing, and government procurement.

By Benjamin H. McCoy and Zac Arbitman

7 minute read